Management of pituitary tumors in pregnancy
- 15 March 2011
- journal article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 7 (5) , 301-310
Abstract
Pituitary tumors, usually adenomas, account for about 10-15% of all intracranial tumors. Their treatment, which includes surgery, medicine or radiotherapy, either isolated or in combination, aims to halt tumor growth or achieve tumor shrinkage, as well as control hormone hypersecretion or ensure hormone replacement. Such approaches have made pregnancy possible for women with pituitary adenomas. Medical therapy with dopamine agonists is the treatment of choice for most patients with prolactinomas, with surgery reserved for individuals resistant to drugs. On the other hand, surgery before conception is indicated as a first-line approach in patients with acromegaly, Cushing disease or clinically nonfunctioning pituitary macroadenomas. In these patient populations, medical therapy with somatostatin analogues (acromegaly) or drugs that target the adrenal glands, such as metyrapone and ketoconazole (Cushing disease), should be reserved for those in whom surgery is unsuccessful or contraindicated.Keywords
This publication has 113 references indexed in Scilit:
- Effects of octreotide exposure during pregnancy in acromegalyClinical Endocrinology, 2010
- Pregnancy and pituitary disordersEuropean Journal of Endocrinology, 2010
- IVF/ICSI in a woman with active acromegaly: Successful outcome following treatment with pegvisomantJournal of Assisted Reproduction and Genetics, 2006
- Pregnancy in acromegaly: a one-center experienceEuropean Journal of Endocrinology, 2006
- Cushing's syndrome secondary to adrenal adenoma during pregnancySurgical Endoscopy, 2001
- A Comparative Review of the Tolerability Profiles of Dopamine Agonists in the Treatment of Hyperprolactinaemia and Inhibition of LactationDrug Safety, 1996
- Maternal–Fetal Transfer of OctreotideNew England Journal of Medicine, 1995
- Pituitary apoplexy in an acromegalic woman operated on during pregnancy by transphenoidal approachInternational Journal of Gynecology & Obstetrics, 1991
- Bromocriptine in pregnancy: Safety aspectsJournal of Molecular Medicine, 1987
- Pregnancy and the Hyperprolactinemic WomanNew England Journal of Medicine, 1985